Autopsy report · NCT05659459

The KIN-FAST Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2

“Sponsor went bankrupt - trial was discontinued due to lack of financing”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 1 year 1 month before it stopped.
• 17 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Kinarus AG

Sponsor type

Industry

Conditions

COVID-19

Interventions

KIN001; KIN001-Placebo

Participants

17

Sites

8

Countries

Germany, Switzerland

Trials that died the same way

• A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
  “Trial was cancelled by Sponsor” (79% match in meaning)
• MRI Gadopiclenol Enhanced Imaging of CNS Tumors
  “The sponsor backed out of the trial.” (76% match in meaning)
• Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone
  “Loss of Financial Sponsor” (75% match in meaning)
• Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
  “Trial terminated by Sponsor.” (75% match in meaning)
• Patient Perception of MultiPulse Therapy™ (MPT™)
  “Sponsor ceased operations” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.